106: Soft Tissue Sarcomas
Soft Tissue Sarcomas Neeta Somaiah and Shreyaskumar Patel The University of Texas MD Anderson Cancer Center, Houston, TX, USA Case study 106.1 A 38-year-old social worker noted a slowly growing…
104: Endometrial and Cervical Cancers
Endometrial and Cervical Cancers Maurie Markman Cancer Treatment Centers of America and Drexel University College of Medicine, Philadelphia, PA, USA Cervical Cancer Case study 104.1 A 39-year-old female is diagnosed…
66: T-Cell Depletion in Allogeneic Hematopoietic Cell Transplantation
T-Cell Depletion in Allogeneic Hematopoietic Cell Transplantation Jenna D. Goldberg and Miguel-Angel Perales Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA Introduction Graft-versus-host disease…
15: Cytogenetics and Prognostic Models in Myelodysplastic Syndromes
Cytogenetics and Prognostic Models in Myelodysplastic Syndromes Uma Borate and Harry P. Erba University of Alabama at Birmingham, Birmingham, AL, USA MDS Cytogenetics and Prognosis Myelodysplastic syndromes (MDS) are a…
60: Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma Jasleen Randhawa1, Veerpal Singh2, and Parameswaran Hari1 1Medical College of Wisconsin, Milwaukee, WI, USA 2Fox Valley Hematology Oncology, Elgin, IL, USA Introduction Due…
103: Ovarian Cancer: Second-Line Treatment Strategies
Ovarian Cancer: Second-Line Treatment Strategies Maurie Markman Cancer Treatment Centers of America and Drexel University College of Medicine, Philadelphia, PA, USA Case study 103.1 A 66-year-old ovarian cancer patient develops…
98: Medical Management of Prostate Cancer
Medical Management of Prostate Cancer Elizabeth K. O’Donnell and Philip Kantoff Dana-Farber Cancer Institute Boston, MA, USA Multiple Choice and Discussion Questions 1. A patient has a rising prostate-specific antigen (PSA)…
97: Prostate Cancer: Screening, Surveillance, Prognostic Algorithms and Independent Pathologic Predictive Parameters
Prostate Cancer: Screening, Surveillance, Prognostic Algorithms and Independent Pathologic Predictive Parameters Megan G. Lockyer and Thomas M. Wheeler Baylor College of Medicine, Houston, TX, USA Case study 97.1 A 56-year-old…
96: Medical Management of Bladder Cancer
Medical Management of Bladder Cancer Gary R. MacVicar and Timothy M. Kuzel Northwestern University Feinberg School of Medicine, Chicago, IL, USA Case study 96.1 A 68-year-old man with muscle invasive…
93: Anal Cancer
Anal Cancer Rob Glynne Jones Mount Vernon Cancer Centre, Northwood, UK Introduction Squamous cell cancer of the anus (SCCA) is a rare disease that makes up approximately 2% of all…
